Cleared Traditional

K873149 - NOVAMETRIX END TIDAL CO2 MONITOR

K873149 is an FDA 510(k) clearance for NOVAMETRIX END TIDAL CO2 MONITOR, manufactured by Novametrix Medical Systems, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K873149 · Novametrix Medical Systems, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1987
Decision
87d
Days
Class 2
Risk

K873149 is an FDA 510(k) clearance for the NOVAMETRIX END TIDAL CO2 MONITOR, MODEL 1260. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Novametrix Medical Systems, Inc. (Wallingford, US). The FDA issued a Cleared decision on November 6, 1987 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Novametrix Medical Systems, Inc. devices

FDA 510(k) Submission Details - K873149

510(k) Number K873149 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 1987
Decision Date November 06, 1987
Days to Decision 87 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 140d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 154
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K873149.
VITALERT 1000 MONITORING SYSTEM
K873380 · Draeger Medical, Inc. · Apr 1988
BIOCHEM 9090 CAPNOGRAPH/SAO2
K873856 · Biochem International, Inc. · Dec 1987
BIOCHEM 8800 CAPNOMETER
K873959 · Biochem International, Inc. · Dec 1987
MODEL 7000 COMBINATION END TIDAL & PULSE OXIMETRY
K874036 · Novametrix Medical Systems, Inc. · Nov 1987
OSCAR(TM) PB255 OXIMETER CAPNOMETER
K872760 · Datex Division Instrumentarium Corp. · Sep 1987
BIOCHEM 8090 CAPNOGRAPH
K871133 · Biochem International, Inc. · Apr 1987